These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31423869)

  • 1. Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
    Agarwal A; Cheung AK; Ma J; Cho M; Li M
    J Am Heart Assoc; 2019 Aug; 8(16):e013098. PubMed ID: 31423869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
    J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.
    Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P
    Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.
    Sharma M; Pearce LA; Benavente OR; Anderson DC; Connolly SJ; Palacio S; Coffey CS; Hart RG
    Stroke; 2014 Oct; 45(10):2989-94. PubMed ID: 25158772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial.
    Field TS; McClure LA; White CL; Pergola PE; Hart RG; Benavente OR; Hill MD;
    Am J Hypertens; 2015 Jun; 28(6):756-64. PubMed ID: 25452300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.
    Odden MC; McClure LA; Sawaya BP; White CL; Peralta CA; Field TS; Hart RG; Benavente OR; Pergola PE
    Hypertension; 2016 Jan; 67(1):63-9. PubMed ID: 26553236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.
    ; Benavente OR; Coffey CS; Conwit R; Hart RG; McClure LA; Pearce LA; Pergola PE; Szychowski JM
    Lancet; 2013 Aug; 382(9891):507-15. PubMed ID: 23726159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.
    Elkind MS; Luna JM; McClure LA; Zhang Y; Coffey CS; Roldan A; Del Brutto OH; Pretell EJ; Pettigrew LC; Meyer BC; Tapia J; White C; Benavente OR;
    Stroke; 2014 Mar; 45(3):707-16. PubMed ID: 24523037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Benavente OR; Peralta CA
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1040-1047. PubMed ID: 28446537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study.
    Palacio S; McClure LA; Benavente OR; Bazan C; Pergola P; Hart RG
    Stroke; 2014 Sep; 45(9):2689-94. PubMed ID: 25034716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.
    Wilson LK; Pearce LA; Arauz A; Anderson DC; Tapia J; Bazan C; Benavente OR; Field TS;
    Int J Stroke; 2016 Jun; 11(4):412-9. PubMed ID: 26956031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial.
    Field TS; Pearce LA; Asinger RW; Smyth NG; De SK; Hart RG; Benavente OR;
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1423-9. PubMed ID: 25840952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
    Ambrosius WT; Sink KM; Foy CG; Berlowitz DR; Cheung AK; Cushman WC; Fine LJ; Goff DC; Johnson KC; Killeen AA; Lewis CE; Oparil S; Reboussin DM; Rocco MV; Snyder JK; Williamson JD; Wright JT; Whelton PK;
    Clin Trials; 2014 Oct; 11(5):532-46. PubMed ID: 24902920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
    Pearce LA; McClure LA; Anderson DC; Jacova C; Sharma M; Hart RG; Benavente OR;
    Lancet Neurol; 2014 Dec; 13(12):1177-85. PubMed ID: 25453457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
    Shoamanesh A; Pearce LA; Bazan C; Catanese L; McClure LA; Sharma M; Marti-Fabregas J; Anderson DC; Kase CS; Hart RG; Benavente OR;
    Ann Neurol; 2017 Aug; 82(2):196-207. PubMed ID: 28681535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
    Leitão L; Soares-Dos-Reis R; Neves JS; Baptista RB; Bigotte Vieira M; Mc Causland FR
    Stroke; 2019 Dec; 50(12):3639-3642. PubMed ID: 31637971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.
    Hart RG; Pearce LA; Bakheet MF; Benavente OR; Conwit RA; McClure LA; Talbert RL; Anderson DC
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):618-24. PubMed ID: 23800503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.